Literature DB >> 20514937

Combined treatment with prednisolone and tacrolimus for myasthenia gravis with invasive thymoma.

Shiroh Miura1, Koichi Azuma, Kazuhiko Yamada, Sinzo Takamori, Akihiko Kawahara, Kazuhito Noda, Mitsuyoshi Ayabe, Masayoshi Kage, Hisamichi Aizawa, Takayuki Taniwaki.   

Abstract

We describe a case of recurrent invasive thymoma associated with myasthenia gravis that responded to combined treatment with prednisolone and tacrolimus. The patient suffered from a myasthenic crisis and received methylprednisolone pulse therapy and partial thymomectomy. Low maintenance doses of prednisolone and tacrolimus shrank the size of the invasive thymoma and maintained the patient without any myasthenic symptoms. We stress the usefulness of combined treatment with tacrolimus and prednisolone for invasive thymoma, especially for unresectable tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514937

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  2 in total

1.  Cyclosporine is a potential curative treatment option for advanced thymoma.

Authors:  Yusuke Isshiki; Hiroaki Tanaka; Yoshio Suzuki; Yukihiro Yoshida
Journal:  Exp Hematol Oncol       Date:  2017-05-03

2.  Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent.

Authors:  Guoyan Qi; Peng Liu; Huimin Dong; Shanshan Gu; Hongxia Yang; Yinping Xue
Journal:  Med Sci Monit       Date:  2017-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.